DK164940C - Polypeptid med human-gamma-interferonaktivitet, genteknologisk fremgangsmaade til fremstilling deraf, hybrid-plasmider indeholdende en dna-sekvens, der koder for peptidet, vaertsorganismer indeholdende hybridplasmiderne, samt laegemidler, som indeholder polypeptidet - Google Patents

Polypeptid med human-gamma-interferonaktivitet, genteknologisk fremgangsmaade til fremstilling deraf, hybrid-plasmider indeholdende en dna-sekvens, der koder for peptidet, vaertsorganismer indeholdende hybridplasmiderne, samt laegemidler, som indeholder polypeptidet

Info

Publication number
DK164940C
DK164940C DK176285A DK176285A DK164940C DK 164940 C DK164940 C DK 164940C DK 176285 A DK176285 A DK 176285A DK 176285 A DK176285 A DK 176285A DK 164940 C DK164940 C DK 164940C
Authority
DK
Denmark
Prior art keywords
human
organide
summaria
polypeptide
peptide
Prior art date
Application number
DK176285A
Other languages
Danish (da)
English (en)
Other versions
DK164940B (da
DK176285D0 (da
DK176285A (da
Inventor
Joachim Engels
Michael Leineweber
Eugen Uhlmann
Wolfgang Ulmer
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of DK176285D0 publication Critical patent/DK176285D0/da
Publication of DK176285A publication Critical patent/DK176285A/da
Publication of DK164940B publication Critical patent/DK164940B/da
Application granted granted Critical
Publication of DK164940C publication Critical patent/DK164940C/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/555—Interferons [IFN]
    • C07K14/57—IFN-gamma
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/811—Interferon
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00—Peptide or protein sequence
    • Y10S930/01—Peptide or protein sequence
    • Y10S930/14—Lymphokine; related peptides
    • Y10S930/142—Interferon

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Saccharide Compounds (AREA)
DK176285A 1984-04-19 1985-04-18 Polypeptid med human-gamma-interferonaktivitet, genteknologisk fremgangsmaade til fremstilling deraf, hybrid-plasmider indeholdende en dna-sekvens, der koder for peptidet, vaertsorganismer indeholdende hybridplasmiderne, samt laegemidler, som indeholder polypeptidet DK164940C (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19843414831 DE3414831A1 (de) 1984-04-19 1984-04-19 Herstellung von polypeptiden mit human-gammainterferon-aktivitaet
DE3414831 1984-04-19

Publications (4)

Publication Number Publication Date
DK176285D0 DK176285D0 (da) 1985-04-18
DK176285A DK176285A (da) 1985-10-20
DK164940B DK164940B (da) 1992-09-14
DK164940C true DK164940C (da) 1993-02-01

Family

ID=6234006

Family Applications (1)

Application Number Title Priority Date Filing Date
DK176285A DK164940C (da) 1984-04-19 1985-04-18 Polypeptid med human-gamma-interferonaktivitet, genteknologisk fremgangsmaade til fremstilling deraf, hybrid-plasmider indeholdende en dna-sekvens, der koder for peptidet, vaertsorganismer indeholdende hybridplasmiderne, samt laegemidler, som indeholder polypeptidet

Country Status (20)

Country Link
US (1) US4832959A (enExample)
EP (1) EP0161504B1 (enExample)
JP (2) JPH0745516B2 (enExample)
KR (1) KR920009505B1 (enExample)
AT (1) ATE69241T1 (enExample)
CA (1) CA1339892C (enExample)
DE (2) DE3414831A1 (enExample)
DK (1) DK164940C (enExample)
ES (1) ES8603574A1 (enExample)
FI (1) FI90436C (enExample)
GR (1) GR850941B (enExample)
HU (1) HU210111B (enExample)
IE (1) IE59460B1 (enExample)
IL (1) IL74947A (enExample)
MA (1) MA20411A1 (enExample)
NO (1) NO171983C (enExample)
NZ (1) NZ211827A (enExample)
PH (1) PH25251A (enExample)
PT (1) PT80300B (enExample)
ZA (1) ZA852900B (enExample)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3409966A1 (de) * 1984-03-19 1985-09-26 Hoechst Ag, 6230 Frankfurt Gentechnologisches verfahren zur herstellung von human-gammainterferon und mittel zur durchfuehrung dieses verfahrens
DE3536939A1 (de) * 1985-10-17 1987-04-23 Hoechst Ag Biologisch aktive derivate des human-(gamma)-interferons, ihre herstellung und arzneimittel, die solche derivate enthalten
GB8619725D0 (en) * 1986-08-13 1986-09-24 Hoffmann La Roche Homogenous interferon fragments
DE3642096A1 (de) * 1986-12-10 1988-06-16 Boehringer Ingelheim Int Pferde-(gamma)-interferon
US5157004A (en) * 1986-12-27 1992-10-20 Takeda Chemical Industries, Ltd. Polypeptides and production thereof
JP2653061B2 (ja) * 1986-12-27 1997-09-10 武田薬品工業株式会社 新規ポリペプチドおよびその製造法
SK8292002A3 (en) * 1999-11-12 2002-12-03 Maxygen Holdings Ltd A conjugate exhibiting interferon gamma activity, nucleotide sequence encoding for a polypeptide fraction of conjugate, an expression vector and a host cell containing nucleotide sequence, pharmaceutical composition comprising the same and use thereof
US7230081B1 (en) 1999-11-12 2007-06-12 Maxygen Holdings, Ltd. Interferon gamma conjugates
US6958388B2 (en) 2001-04-06 2005-10-25 Maxygen, Aps Interferon gamma polypeptide variants
US7038015B2 (en) * 2001-04-06 2006-05-02 Maxygen Holdings, Ltd. Interferon gamma polypeptide variants
AU2003239774A1 (en) * 2002-07-03 2004-01-23 Maxygen Holdings Ltd. Full-length interferon gamma polypeptide variants
US20050003533A1 (en) * 2003-05-08 2005-01-06 Pawel Kalinski Mature type-1 polarized dendritic cells with enhanced IL-12 production and methods of serum-free production and use
BG66458B1 (bg) 2005-03-21 2014-10-31 Иван Иванов Средство за конкурентно инхибиране на ендогенен гама интерферон
CA2607806A1 (en) * 2005-05-04 2006-11-16 Nautilus Biotech, S.A. Modified interferon-gamma polypeptides and methods for using modified interferon-gamma polypeptides
US7655216B2 (en) * 2007-02-26 2010-02-02 University of Pittsburgh - of the Commonwealth of Higher Education Vaccine for activating helper function of CD8+ Tcells
US9359421B2 (en) 2008-04-08 2016-06-07 Tigo Gmbh Suppressor of the endogenous interferon-gamma
BG66517B1 (bg) 2008-04-08 2016-02-29 Tigo Gmbh Супресор на ендогенния човешки гама - интерферон
JP4821891B2 (ja) * 2009-07-01 2011-11-24 トヨタ自動車株式会社 電池制御システム及び車両
BG67190B1 (bg) 2017-03-29 2020-11-16 Tigo Gmbh Анти-гама мутантен протеин срещу ендогенния човешки гама интерферон
CN120623346A (zh) 2018-10-11 2025-09-12 因荷布瑞克斯生物科学公司 Pd-1单结构域抗体及其治疗组合物
JP7611820B2 (ja) 2018-10-11 2025-01-10 インヒブルクス バイオサイエンシズ インコーポレイテッド Ｄｌｌ３シングルドメイン抗体およびその治療用組成物
TW202506736A (zh) 2018-10-11 2025-02-16 美商因荷布瑞克斯生物科學公司 5t4單域抗體及其治療性組合物
US20230124851A1 (en) 2018-10-11 2023-04-20 Inhibrx, lnc. B7h3 single domain antibodies and therapeutic compositions thereof

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU561343B2 (en) * 1981-10-19 1987-05-07 Genentech Inc. Human immune interferon by recombinant dna
JPS58110548A (ja) * 1981-12-24 1983-07-01 Asahi Chem Ind Co Ltd 新規な生理活性ペプチド
ZA831094B (en) * 1982-02-22 1983-11-30 Biogen Nv Dna sequences,recombinant dna molecules and processes for producing human immune interferon-like polypeptides
IL68100A0 (en) * 1982-03-24 1983-06-15 Takeda Chemical Industries Ltd Novel dna and use thereof
US6936694B1 (en) * 1982-05-06 2005-08-30 Intermune, Inc. Manufacture and expression of large structural genes
JPH0787797B2 (ja) * 1982-05-20 1995-09-27 サントリー株式会社 ヒト・ガンマ・インタ−フエロン様ポリペプチドの製造法
US4681848A (en) * 1982-09-22 1987-07-21 Takeda Chemical Industries, Ltd. Novel peptide and use thereof
US4604284A (en) * 1983-09-20 1986-08-05 Hoffmann-La Roche Inc. Homogeneous immune interferon fragment
US4855238A (en) * 1983-12-16 1989-08-08 Genentech, Inc. Recombinant gamma interferons having enhanced stability and methods therefor

Also Published As

Publication number Publication date
PT80300B (pt) 1987-09-30
MA20411A1 (fr) 1985-12-31
ES542337A0 (es) 1985-12-16
PT80300A (de) 1985-05-01
US4832959A (en) 1989-05-23
GR850941B (enExample) 1985-11-25
ZA852900B (en) 1985-11-27
JPH07100037B2 (ja) 1995-11-01
NO171983C (no) 1993-05-26
JPH06153957A (ja) 1994-06-03
PH25251A (en) 1991-03-27
IL74947A0 (en) 1985-08-30
FI851529L (fi) 1985-10-20
JPH0745516B2 (ja) 1995-05-17
NZ211827A (en) 1988-07-28
ES8603574A1 (es) 1985-12-16
IL74947A (en) 2000-06-01
ATE69241T1 (de) 1991-11-15
IE850995L (en) 1985-10-19
DE3584579D1 (de) 1991-12-12
CA1339892C (en) 1998-06-02
IE59460B1 (en) 1994-02-23
HUT37815A (en) 1986-02-28
FI851529A0 (fi) 1985-04-17
KR920009505B1 (ko) 1992-10-17
NO851564L (no) 1985-10-21
HU210111B (en) 1995-02-28
FI90436C (fi) 1994-02-10
FI90436B (fi) 1993-10-29
EP0161504B1 (de) 1991-11-06
DK164940B (da) 1992-09-14
JPS60233100A (ja) 1985-11-19
NO171983B (no) 1993-02-15
DK176285D0 (da) 1985-04-18
KR850007274A (ko) 1985-12-02
DE3414831A1 (de) 1985-10-31
DK176285A (da) 1985-10-20
EP0161504A1 (de) 1985-11-21

Similar Documents

Publication Publication Date Title
DK164940C (da) Polypeptid med human-gamma-interferonaktivitet, genteknologisk fremgangsmaade til fremstilling deraf, hybrid-plasmider indeholdende en dna-sekvens, der koder for peptidet, vaertsorganismer indeholdende hybridplasmiderne, samt laegemidler, som indeholder polypeptidet
EG19101A (en) Process for preparing of expression of human proapolipoprotein A.1.
ATE80660T1 (de) Verfahren zur herstellung eines polypeptides.
DE68922917D1 (de) KEX2-Endoprotease und Verfahren zu ihrer Herstellung.
NO882946L (no) Konstruksjon av syntetisk dna og anvendelse derav i syntese av store polypeptider.
HUT46061A (en) Dna sequences encoding hirudin-like protein and process for producing such proteins
DE69333346T2 (de) Neuartiges p- selectin ligandenprotein
ATE91722T1 (de) Pferde-gamma-interferon.
DE3751269D1 (de) Expression des biologisch aktiven Faktors XIII.
IL75963A (en) Omega interferon polypeptides of type 1,n-glycosylated derivatives thereof with omega interferon activity,polynucleotide sequences encoding the omega interferon polypeptides,methods for the preparation of the polypeptides and pharmaceutical compositions containing them
ATE89317T1 (de) Proteine, expressionsvektoren, die fuer solche proteine kodierende dna enthalten und zellen, die solche expressionsvektoren enthalten.
NO873437D0 (no) Human placenta angiogen faktor i stand til aa stimulere kapillaer endotelcelle-proteasesyntese, dna-syntese og migrasjon.
KR880009127A (ko) 용성 성숙 hIL-β 및 변경된 생물학적 활성을 갖는 유도체를 이 콜라이에서 고도로 발현시키는 플라즈미드 및 그 방법
DE68920321D1 (de) Verfahren zur herstellung eines menschlichen "neutrophil chemotactic factor"-polypeptids.
ES2039390T3 (es) Un procedimiento para producir un factor de diferenciacion de celulas b humanas.
DK0555785T3 (da) Glat-muskel-mitogent stof og DNA, der koder herfor
BR1100940A (pt) Polipeptìdeos puros, sequências adn, molécula adn recombinada, célula hospedeira, processo de manipulação genética para produção de polipeptìdeo, e, uso de um polipeptìdeo
KR890002399A (ko) 하이브리드 인터페론 및 재조합 dna기술을 이용한 그의 제조방법

Legal Events

Date Code Title Description
PBP Patent lapsed